◼ Archived
Business
🔮 fades ✓
Johnson & Johnson Sees $5.5B End to Its Headache
Johnson & Johnson proposes a $5.5 billion settlement to resolve United States talcum powder litigation.
Johnson & Johnson
7 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
Johnson & Johnson proposes a $5.5 billion settlement to potentially resolve marathon talc litigation.
◼ Archived
Business
🔮 fades ✓
J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer
Johnson & Johnson proposes a multi-billion dollar payout to resolve ongoing legal battles.
◼ Archived
Business
🔮 holds ✓
Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
Johnson & Johnson has proposed a $5.5 billion settlement to resolve a decade-long legal battle over cancer claims linked to its baby powder.
◼ Archived
Business
🔮 fades
Johnson & Johnson CFO Says Guidance Hike Is Just the Start
Johnson & Johnson shares dip despite a Q2 earnings beat, revenue growth, and an increased full-year guidance raise announced by the CFO.
◼ Archived
Business
🔮 fades
Cure for certain cancers is ‘realistic’ goal in next decade, pharma lead says
Johnson & Johnson CEO Joaquin Duato identifies the development of cures for certain types of cancer as a realistic objective for the coming decade.
◼ Archived
Business
🔮 fades
Johnson & Johnson CEO credits Trump tax policy for $55B US investment push, including $1B in Florida
Johnson & Johnson is directing $55 billion into US operations, linking the strategy to tax policy.